BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 28467275)

  • 41. Interplay between interferon-stimulated gene 15/ISGylation and interferon gamma signaling in breast cancer cells.
    Tecalco-Cruz AC; Cortés-González CC; Cruz-Ramos E; Ramírez Jarquín JO; Romero-Mandujano AK; Sosa-Garrocho M
    Cell Signal; 2019 Feb; 54():91-101. PubMed ID: 30500379
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitrosylation of ISG15 prevents the disulfide bond-mediated dimerization of ISG15 and contributes to effective ISGylation.
    Okumura F; Lenschow DJ; Zhang DE
    J Biol Chem; 2008 Sep; 283(36):24484-8. PubMed ID: 18606809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interferon-stimulated gene 15 and ISGylation are upregulated in glioblastoma.
    Tecalco-Cruz AC; Velasco-Loyden G; Robles-Villarruel L; Cortes-González CC; Zepeda-Cervantes J; Pineda B; Chagoya de Sánchez V
    Biochem Biophys Res Commun; 2022 Sep; 621():144-150. PubMed ID: 35834923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging role of ISG15 in antiviral immunity.
    Skaug B; Chen ZJ
    Cell; 2010 Oct; 143(2):187-90. PubMed ID: 20946978
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ISG15, a Small Molecule with Huge Implications: Regulation of Mitochondrial Homeostasis.
    Albert M; Bécares M; Falqui M; Fernández-Lozano C; Guerra S
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30428561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ISG15: its roles in SARS-CoV-2 and other viral infections.
    Sarkar L; Liu G; Gack MU
    Trends Microbiol; 2023 Dec; 31(12):1262-1275. PubMed ID: 37573184
    [TBL] [Abstract][Full Text] [Related]  

  • 47. NK cells and interferons.
    Paolini R; Bernardini G; Molfetta R; Santoni A
    Cytokine Growth Factor Rev; 2015 Apr; 26(2):113-20. PubMed ID: 25443799
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation.
    Lu G; Reinert JT; Pitha-Rowe I; Okumura A; Kellum M; Knobeloch KP; Hassel B; Pitha PM
    Cell Mol Biol (Noisy-le-grand); 2006 May; 52(1):29-41. PubMed ID: 16914094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ISG15 in Host Defense Against Candida albicans Infection in a Mouse Model of Fungal Keratitis.
    Dong C; Gao N; Ross BX; Yu FX
    Invest Ophthalmol Vis Sci; 2017 Jun; 58(7):2948-2958. PubMed ID: 28599020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ubiquitin-like Molecule ISG15 Acts as an Immune Adjuvant to Enhance Antigen-specific CD8 T-cell Tumor Immunity.
    Villarreal DO; Wise MC; Siefert RJ; Yan J; Wood LM; Weiner DB
    Mol Ther; 2015 Oct; 23(10):1653-62. PubMed ID: 26122932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of myeloid-derived suppressor cells in chronic infectious diseases and the current methodology available for their study.
    Peñaloza HF; Alvarez D; Muñoz-Durango N; Schultz BM; González PA; Kalergis AM; Bueno SM
    J Leukoc Biol; 2019 May; 105(5):857-872. PubMed ID: 30480847
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human rhinovirus-induced ISG15 selectively modulates epithelial antiviral immunity.
    Zaheer RS; Wiehler S; Hudy MH; Traves SL; Pelikan JB; Leigh R; Proud D
    Mucosal Immunol; 2014 Sep; 7(5):1127-38. PubMed ID: 24448099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ISG15 and ISGylation in Human Diseases.
    Mirzalieva O; Juncker M; Schwartzenburg J; Desai S
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159348
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Free ISG15 triggers an antitumor immune response against breast cancer: a new perspective.
    Burks J; Reed RE; Desai SD
    Oncotarget; 2015 Mar; 6(9):7221-31. PubMed ID: 25749047
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An Approach for the Identification of Proteins Modified with ISG15.
    Takeuchi T; Koinuma S; Yokosawa H; Arata Y
    Methods Mol Biol; 2019; 1934():235-246. PubMed ID: 31256383
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling.
    Kim KI; Yan M; Malakhova O; Luo JK; Shen MF; Zou W; de la Torre JC; Zhang DE
    Mol Cell Biol; 2006 Jan; 26(2):472-9. PubMed ID: 16382139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ISG15 inhibits cancer cell growth and promotes apoptosis.
    Zhou MJ; Chen FZ; Chen HC; Wan XX; Zhou X; Fang Q; Zhang DZ
    Int J Mol Med; 2017 Feb; 39(2):446-452. PubMed ID: 28035359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammation-dependent ISG15 upregulation mediates MIA-induced dendrite damages and depression by disrupting NEDD4/Rap2A signaling.
    Hu Y; Hong XY; Yang XF; Ma RH; Wang X; Zhang JF; Feng Q; Li XG; Sun DS; Li X; Wan HL; Li T; Wang Q; Ke D; Wang JZ; Liu GP
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1477-1489. PubMed ID: 30826466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.
    Kim KI; Giannakopoulos NV; Virgin HW; Zhang DE
    Mol Cell Biol; 2004 Nov; 24(21):9592-600. PubMed ID: 15485925
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular ISG15 Signals Cytokine Secretion through the LFA-1 Integrin Receptor.
    Swaim CD; Scott AF; Canadeo LA; Huibregtse JM
    Mol Cell; 2017 Nov; 68(3):581-590.e5. PubMed ID: 29100055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.